uniQure’s experimental gene therapy AMT-130 safely and effectively slows the progression of Huntington’s disease, according to top-line, three-year data from two Phase 1/2 clinical trials. At 36 months, the use […] The post Gene therapy AMT-130 slows Huntington’s progression by 75% appeared first on Huntington's Disease News.
